Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis

Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis

Background: Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal interstitial lung disease (ILD). Currently, two antifibrotic drugs are available for reducing forced vital capacity (FVC) decline in IPF. However, many pulmonologists wait before initiating treatment, especially when IPF pati...

Full description

Bibliographic Details
Main Authors:	Yuya Aono, Yutaro Nakamura, Masato Kono, Hidenori Nakamura, Koshi Yokomura, Shiro Imokawa, Mikio Toyoshima, Hideki Yasui, Hironao Hozumi, Masato Karayama, Yuzo Suzuki, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui, Takafumi Suda
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-09-01
Series:	Therapeutic Advances in Respiratory Disease
Online Access:	https://doi.org/10.1177/1753466620953783

Similar Items

Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study
by: Yuzo Suzuki, et al.
Published: (2021-07-01)

Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosis
by: Yuzo Suzuki, et al.
Published: (2021-09-01)

Impact of end-of-life respiratory modalities on quality of dying and death and symptom relief in patients with interstitial lung disease: a multicenter descriptive cross-sectional study
by: Takafumi Koyauchi, et al.
Published: (2022-04-01)

Prognostic classification in acute exacerbation of idiopathic pulmonary fibrosis: a multicentre retrospective cohort study
by: Takahito Suzuki, et al.
Published: (2021-04-01)

Neutrophil–lymphocyte ratio in patients with idiopathic pleuroparenchymal fibroelastosis
by: Yuzo Suzuki, et al.
Published: (2023-11-01)

Pulse oximetric saturation to fraction of inspired oxygen (SpO/FIO) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease
by: Takafumi Koyauchi, et al.
Published: (2020-02-01)

Assessment of malnutrition-related risk in patients with idiopathic pleuroparenchymal fibroelastosis
by: Yuzo Suzuki, et al.
Published: (2023-05-01)

Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias.
by: Hironao Hozumi, et al.
Published: (2018-01-01)

Prognostic and Clinical Value of Cluster Analysis in Idiopathic Pleuroparenchymal Fibroelastosis Phenotypes
by: Yutaro Nakamura, et al.
Published: (2021-04-01)

Utility of serum Aspergillus-galactomannan antigen to evaluate the risk of severe acute exacerbation in chronic obstructive pulmonary disease.
by: Katsuhiro Yoshimura, et al.
Published: (2018-01-01)

Predictors for bronchoalveolar lavage recovery failure in diffuse parenchymal lung disease
by: Keigo Koda, et al.
Published: (2021-01-01)

Standardised 3D-CT lung volumes for patients with idiopathic pulmonary fibrosis
by: Yuko Tanaka, et al.
Published: (2022-06-01)

Comparative assessment of NOIR-SS and ddPCR for ctDNA detection of EGFR L858R mutations in advanced L858R-positive lung adenocarcinomas
by: Daisuke Akahori, et al.
Published: (2021-07-01)

Multiple organ infarction caused by aortic thrombus in a lung cancer patient with the BRAF mutation
by: Hirofumi Watanabe, et al.
Published: (2022-01-01)

Trimethoprim-sulfamethoxazole induced eosinophilic pneumonia: A case report
by: Yasutaka Mochizuka, et al.
Published: (2022-01-01)

Associations of serum long-chain fatty acids with multiple organ involvement in patients with sarcoidosis
by: Takahito Suzuki, et al.
Published: (2022-07-01)

Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis
by: Noriyuki Enomoto, et al.
Published: (2020-06-01)

Prognostic factors for myositis-associated interstitial lung disease.
by: Tomoyuki Fujisawa, et al.
Published: (2014-01-01)

Conventional type 2 lung dendritic cells are potent inducers of follicular helper T cells in the asthmatic lung
by: Shogo Sakurai, et al.
Published: (2021-07-01)

Cluster analysis-based clinical phenotypes of idiopathic interstitial pneumonias: associations with acute exacerbation and overall survival
by: Yoichiro Aoshima, et al.
Published: (2021-02-01)

Effect of Hypoxia on Pulmonary Endothelial Cells from Bleomycin-Induced Pulmonary Fibrosis Model Mice
by: Daisuke Akahori, et al.
Published: (2022-08-01)

Macrophage mannose receptor, CD206, predict prognosis in patients with pulmonary tuberculosis
by: Yuzo Suzuki, et al.
Published: (2018-09-01)

EGFR-mutated, metastatic pulmonary pleomorphic carcinoma successfully treated with afatinib
by: Akira Kawamura, et al.
Published: (2022-06-01)

Influenza A virus enhances ciliary activity and mucociliary clearance via TLR3 in airway epithelium
by: Yosuke Kamiya, et al.
Published: (2020-10-01)

Impact of preexisting interstitial lung disease on mortality in COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study
by: Koichi Miyashita, et al.
Published: (2024-02-01)

Changes in the characteristics and outcomes of COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study
by: Koichi Miyashita, et al.
Published: (2023-12-01)

Frequency, proportion of PF-ILD, and prognostic factors in patients with acute exacerbation of ILD related to systemic autoimmune diseases
by: Noriyuki Enomoto, et al.
Published: (2022-10-01)

Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysis
by: Koichi Miyashita, et al.
Published: (2021-10-01)

Low-dose Fluticasone Propionate in Combination With Salmeterol in Patients With Chronic Obstructive Pulmonary Disease
by: Hideki Yasui, et al.
Published: (2018-05-01)

A case of treatment with voriconazole for chronic progressive pulmonary aspergillosis in a patient receiving tacrolimus for dermatomyositis-associated interstitial lung disease
by: Eisuke Mochizuki, et al.
Published: (2015-01-01)

Radiological pleuroparenchymal fibroelastosis-like lesion in idiopathic interstitial pneumonias
by: Tomoyuki Fujisawa, et al.
Published: (2021-11-01)

Effects of long-acting muscarinic antagonists on promoting ciliary function in airway epithelium
by: Mineo Katsumata, et al.
Published: (2022-05-01)

Chemotherapy for patients with advanced lung cancer with interstitial lung disease: a prospective observational study
by: Keigo Koda, et al.
Published: (2022-06-01)

Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study.
by: Hironao Hozumi, et al.
Published: (2015-01-01)

Pan-cancer assessment of antineoplastic therapy-induced interstitial lung disease in patients receiving subsequent therapy immediately following immune checkpoint blockade therapy
by: Yoshihiro Kitahara, et al.
Published: (2024-01-01)

Idiopathic pleuroparenchymal fibroelastosis: consideration of a clinicopathological entity in a series of Japanese patients
by: Kusagaya Hideki, et al.
Published: (2012-12-01)

Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPD
by: Suzuki Y, et al.
Published: (2019-08-01)

Six-week oral prednisolone therapy for immune-related pneumonitis: a single-arm phase II study
by: Hiroyuki Matsuda, et al.
Published: (2023-07-01)

Usual interstitial pneumonia preceding collagen vascular disease: a retrospective case control study of patients initially diagnosed with idiopathic pulmonary fibrosis.
by: Masato Kono, et al.
Published: (2014-01-01)

Effects of indacaterol versus tiotropium on respiratory mechanics assessed by the forced oscillation technique in patients with chronic obstructive pulmonary disease
by: Inui N, et al.
Published: (2015-06-01)